HR蛋白是细胞核受体辅阻遏物的发现证明HR蛋白是通过在毛发周期中调节基因表达来发挥作用的。
The discovery that the HR protein is a nuclear receptor corepressor indicated that HR function in hair cycling is by regulating gene expression.
用酶联免疫吸附法检测血浆血管性假性血友病因子、凝血酶调节蛋白、纤溶酶原激活物抑制物1水平。
The von Willebrand's disease factors in plasm, adjusted protein of thrombase and inhibitor 1 of activator of plasminogen were detected with enzyme-linked immunosorbent assay.
目的研究补体调节蛋白CD59通过阻止补体攻膜复合物(mac)的形成发挥其对依赖补体血小板损伤的保护作用。
AIM to study the protective action of complement regulatory protein CD59 on complement dependent platelet injury by preventing the formation of membrane attack complex (MAC).
化合物筛选的高效率和基因指纹技术的进步，如微阵列技术和蛋白质组学，将加速有效的选择性受体调节子鉴定。
Advancement in high throughput compound screening and gene fingerprinting technologies, such as microarrays and proteomics, will facilitate and accelerate identification of effective SARMs.
当细胞被裂解提取全细胞提取物时，会发生正常的细胞调节缺失，并且细胞提取物中的内源性蛋白酶可以在失控的情况下使蛋白发生降解。
A loss of normal cellular control occurs during cell lysis, and endogenous proteases within the cell extract are free to degrade proteins in an uncontrolled manner.
本发明涉及鉴别一种或一种以上候选化合物是否为G蛋白偶合受体（GPCR）的调 节物或血糖浓度调节物的方法。
The present invention relates to methods of identifying whether one or more candidate compounds is a modulator of a G protein-coupled receptor (GPCR) or a modulator of blood glucose concentration.
还提供了组合物，其包含调节含有CARD的蛋白的试剂。
Further provided are compositions comprising agents that modulate CARD containing proteins.
水溶性维生素也是蛋白质、脂肪和碳水化合物（能量）中间代谢的调节物，缺乏其中的一种都会增加其他品种需求。
Water soluble vitamins are also regulatorsof the intermediary metabolism of protein, fats and carbohydrates (energy) anda lack of any one can increase the need for the others.
p42是泛素蛋白水解酶通路中26s蛋白水解酶复合体19s帽状调节复合物的一个亚基，也是组成19s调节复合物依赖的蛋白水解酶调节子的一个组成成分。
P42 is one subunit of 19s regulatory complex of 26s proteasome in ubiquitin-proteasome pathway, and it is also one subunit of modulator, which is 19s regulatory complex dependent.
发现本发明化合物是烟碱样乙酰胆碱受体的胆碱能配体和单胺受体和转运蛋白的调节剂。
The compounds of the invention are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters.
发现本发明化合物是烟碱样乙酰胆碱受体的胆碱能配体和单胺受体和转运蛋白的调节剂。
The compounds of the invention are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters.
应用推荐